Ironwood Pharma remains undervalued despite a failed $1bn Vectiv Bio acquisition and subsequent stock plunge, with Linzess ...

The U.S. Department of Health and Human Services has set the Maximum Fair Price for LINZESS (linaclotide) at $136 for a 30-day equivalent supply, according to a statement from Ironwood Pharmaceuticals ...

The latest round of Medicare price cuts affect 15 drugs, including Xtandi, an older prostate cancer drug from Pfizer and ...

Ironwood Pharma ( ($IRWD) ) has shared an announcement. On November 25, 2025, the U.S. Department of Health and Human Services announced the ...

President Donald Trump’s administration announced that Medicare will pay reduced prices for 15 prescription drugs, including commonly used weight-loss and cancer medications. At such a critical moment ...

As of Wednesday, November 26, Ironwood Pharmaceuticals, Inc.’s IRWD share price has surged by 6.71%, which has investors questioning if this is right time to sell.

New Medicare-negotiated prices for 15 widely used medications take effect in 2027, impacting more than 5 million ...

The Centers for Medicare and Medicaid Services on Tuesday announced lower prices on 15 costly prescription drugs under ...

The Centers for Medicare & Medicaid Services announced Nov. 25 that Medicare recipients will pay less for 15 prescription ...

The Trump administration late Tuesday announced new lower Medicare prices for 15 drugs that were part of the latest round of the program’s price negotiations, touting a total of $12 billion saved ...

A new round of Medicare drug price negotiations shows the impact of the Inflation Reduction Act while exposing an ongoing political fight over who deserves credit for lowering drug costs. The Trump ...

The U.S. government is expected this week to announce negotiated prices for 15 of the highest-cost prescription drugs under ...